Menu
Search
|

Menu

Close
X

Edap Tms SA EDAP.OQ (NASDAQ Stock Exchange Global Market)

3.19 USD
-0.13 (-3.92%)
As of 4:00 PM EDT
chart
Previous Close 3.32
Open 3.29
Volume 14,324
3m Avg Volume 79,344
Today’s High 3.29
Today’s Low 3.19
52 Week High 4.24
52 Week Low 2.09
Shares Outstanding (mil) 29.37
Market Capitalization (mil) 97.09
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.50 Mean rating from 2 analysts

KEY STATS

Revenue (mm, EUR)
FY18
9
FY17
36
FY16
36
FY15
32
EPS (EUR)
FY18
0.003
FY17
-0.026
FY16
0.130
FY15
-0.070
*Note: Units in Millions of Euro
**Note: Units in Euro

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.89
Price to Sales (TTM)
vs sector
2.30
8.00
Price to Book (MRQ)
vs sector
--
4.21
Price to Cash Flow (TTM)
vs sector
--
22.15
Total Debt to Equity (MRQ)
vs sector
--
17.41
LT Debt to Equity (MRQ)
vs sector
--
13.26
Return on Investment (TTM)
vs sector
--
13.14
Return on Equity (TTM)
vs sector
--
15.15

EXECUTIVE LEADERSHIP

Philippe Chauveau
Independent Chairman of the Board, Since 2004
Salary: --
Bonus: --
Marc Oczachowski
Chief Executive Officer and Director, Since 2012
Salary: --
Bonus: --
Pierre Beysson
Independent Director, Since 2002
Salary: --
Bonus: --
Robrecht Michiels
Independent Director, Since 2009
Salary: --
Bonus: --
Argil Wheelock
Independent Director, Since 2009
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

Parc Activite
La Poudrette Lamartine
4/6 Rue du Dauphine
VAULX-EN-VELIN     69120

Phone: +334.72153150

EDAP TMS S.A. (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors. The Company also produces and commercializes medical equipment for treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL) and distributes other types of urology devices in certain countries. The HIFU division is engaged in the development, manufacturing and marketing of medical devices based on HIFU technology for the invasive treatment of urological and other clinical indications. The UDS division is engaged in the development, marketing, manufacturing and servicing of medical devices for the invasive diagnosis or treatment of urological disorders, urinary stones, and other clinical indications.

SPONSORED STORIES